Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,108.5
37.4 (1.22%)

 

  • STI Straits Times Index
    3,108.5
    37.4 (1.22%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,624.8
    13.0 (0.80%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,773.2
    232.4 (0.81%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,359.3
    -62.1 (-1.82%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,027.9
    284.7 (0.99%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,199.6
    -48.8 (-0.78%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2,029.3M
  • Value: 2,278.4M
  • Rise: 191
  • Fall: 143
  • Unch: 441

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Oceanus^0.033-0.010
Sembcorp Marine0.164+0.004
Jiutian Chemical0.083+0.003
CWX Global0.005-
ThaiBev0.730+0.005
Thomson Medical0.107+0.003
YZJ Shipbldg SGD1.100-0.010
Shen Yao0.004-
ComfortDelGro1.700+0.060
Enviro-Hub0.075+0.002

World Indices

World Indices
Name Last Change
Nasdaq 12,609.2 -311.0
HSI 28,773.2 +232.4
HSCEI 10,973.1 -41.6
Jakarta 6,199.6 -48.8
Nikkei 225 29,027.9 +284.7
SSE Comp 3,359.3 -62.1
Shanghai A 3,521.1 -65.2
Shanghai B 240.6 -0.6
KOSPI 2,976.1 -20.0

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

MATINAS BIOPHARMA HOLDINGS INC MATINAS BIOPHARMA HOLDINGS
Updated on 08 Mar 2021 (End of trading day)
Last (USD): 1.120 Change: - High: 1.200 Remarks: -
Change (%): - Low: 1.080
Open 1.120 Yesterday's Close 1.12
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 1,834,290 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.19894 Trailing EPS (USD) e -0.24453 NAV (USD) b 0.6985
PE a - Trailing PE f - Price / NAV b 1.6034
Dividend (USD) d - Cash In Hand (USD) g 0.0787 Issued & Paid-up Shares c 199,642,000
Dividend Yield (%) d - Price / Cash In Hand g 14.231 Treasury Shares h -
Market Cap (M) 103.009 Enterprise Value (M) 47.888
Piotroski F Score 1 Exchange Code MTNB Par Value ( $ ) n.a.
52 Weeks Volatility (%) 96.02 Free Float (%) 92.9
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 18 Dec 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 02 Mar 2017.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference MATINAS BIOPHARMA HOLDINGS INC NYSE American 103.009 - - 1.6034 -
Industry Biotechnology NYSE American 155.670 - - 3.6656 -
Local Peer ACTINIUM PHARMACEUTICALS INC NYSE American 630.565 - - 13.8806 -
Local Peer NANOVIRICIDES INC NYSE American 313.468 - - 11.2980 -
Local Peer LINEAGE CELL THERAPEUTICS INC NYSE American 265.484 - - 2.9088 -
Local Peer 22ND CENTURY GROUP INC NYSE American 222.989 - - 4.4568 -
Local Peer CEL-SCI CORP NYSE American 168.608 - - 5.8471 -
Local Peer BIOMX INC NYSE American 158.545 - - 2.4081 -
Local Peer IBIO INC NYSE American 134.588 - - 1.2539 -
Local Peer PALATIN TECHNOLOGIES INC NYSE American 104.257 - - 1.5371 -
Local Peer ARMATA PHARMACEUTICALS INC NYSE American 97.478 - - 3.9595 -
Local Peer AIM IMMUNOTECH INC NYSE American 81.780 - - 1.3544 -
Local Peer SYNTHETIC BIOLOGICS INC NYSE American 76.192 - - -8.8276 -
Local Peer INDIA GLOBALIZATION CAPITAL INC NYSE American 48.304 - - 2.2498 -
Other Local Peers ORAGENICS INC (NYSE American), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), NOVABAY PHARMACEUTICALS INC (NYSE American)
Global Peer AMGEN INC NASDAQ 131,575.310 18.113 18.113 13.9840 2.813
Global Peer GILEAD SCIENCES INC NASDAQ 81,364.202 661.524 661.498 4.4701 4.192
Global Peer ILLUMINA INC NASDAQ 55,970.158 85.320 85.320 11.9238 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 55,522.257 20.475 20.475 6.3915 -
Global Peer MODERNA INC NASDAQ 49,359.602 - - 19.2708 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 49,622.457 14.125 14.125 4.5008 -
Global Peer WUXI BIO HKEx 350,073.972 304.523 243.122 23.4351 -
Global Peer BIOGEN INC NASDAQ 41,132.243 10.282 10.282 3.8440 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 32,990.391 54.674 54.674 2.8315 -
Global Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 26,985.532 - - 6.9744 -
Other Global Peers SEAGEN INC (NASDAQ), 10X GENOMICS INC (NASDAQ), BEIGENE (HKEx), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SINO BIOPHARM (HKEx), INCYTE CORPORATION (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), BIO-TECHNE CORP (NASDAQ), NOVAVAX INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ZAI LAB-SB (HKEx), MIRATI THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), JOINN (HKEx), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), Lonza (SGX), PTC THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), INSMED INC (NASDAQ), ARVINAS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), GENSCRIPT BIO (HKEx), AGIOS PHARMACEUTICALS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), VERACYTE INC (NASDAQ), ALKERMES PLC (NASDAQ), NANTKWEST INC (NASDAQ), VIELA BIO INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), SEER INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), 3SBIO (HKEx), LIGAND PHARMACEUTICAL INC (NASDAQ), NUVATION BIO INC (NYSE), KYMERA THERAPEUTICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), ALLOVIR INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), STOKE THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), PRECIGEN INC (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), REGENXBIO INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), OCUGEN INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), BIOATLA INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), VIVA BIOTECH (HKEx), JACOBIO-B (HKEx), JW THERAP-B (HKEx), LUMINEX CORP(DEL) (NASDAQ), ALPHAMAB-B (HKEx), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), MACROGENICS INC (NASDAQ), UNIQURE N.V. (NASDAQ), NKARTA INC (NASDAQ), CYTOKINETICS INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), ALECTOR INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), IMMUNOVANT INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), VOR BIOPHARMA INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), POLYNOVO LIMITED (ASX), HAOHAI BIOTEC (HKEx), ITEOS THERAPEUTICS INC (NASDAQ), VAXCYTE INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), FRONTAGE (HKEx), COHERUS BIOSCIENCES INC (NASDAQ), OMEROS CORP (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), JHBP-B (HKEx), CORTEXYME INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), MESOBLAST LTD (ASX), BIOXCEL THERAPEUTICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), ASCENTAGE-B (HKEx), PASSAGE BIO INC (NASDAQ), PERSONALIS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), INHIBRX INC (NASDAQ), EPIZYME INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), KINTOR PHARMA-B (HKEx), MERUS B V (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), CURIS INC (NASDAQ), TELIX PHARMACEUTIC (ASX), SOLID BIOSCIENCES INC (NASDAQ), CHIMERIX INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), KADMON HLDGS INC (NASDAQ), HUMANIGEN INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), VAXART INC (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), COMPUGEN (NASDAQ), ATRECA INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), IMMATICS N V (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), AFFIMED N V (NASDAQ), AGENUS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), ARDELYX INC (NASDAQ), AKOUOS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), XBIOTECH INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), IVERIC BIO INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), SINOMAB BIO-B (HKEx), ALDEYRA THERAPEUTICS (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), ALTIMMUNE INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), AVROBIO INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), DPHARMA (Bursa), SINOVAC BIOTECH LTD (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), ADICET BIO INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), XOMA CORP (NASDAQ), LEE'S PHARM (HKEx), ESSEX BIO-TECH (HKEx), ASCLETIS-B (HKEx), CUE BIOPHARMA INC (NASDAQ), OPTHEA LIMITED (ASX), PORTAGE BIOTECH INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), SESEN BIO INC (NASDAQ), SQZ BIOTECHNOLOGIES CO (NYSE), VERASTEM INC (NASDAQ), ATHERSYS INC (NASDAQ), ONCORUS INC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), IMUGENE LIMITED (ASX), CO DIAGNOSTICS INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), TREVENA INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), IMMUNOME INC (NASDAQ), NEXTCURE INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), KAMADA LTD (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), MEDICINOVA INC (NASDAQ), CABALETTA BIO INC (NASDAQ), ANTEOTECH LIMITED (ASX), LARIMAR THERAPEUTICS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), METACRINE INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), IMV INC (NASDAQ), INMUNE BIO INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), BIOVIE INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), EQUILLIUM INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), BIONOMICS LTD (ASX), NEXT SCIENCE LTD (ASX), SEELOS THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), CHIASMA INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ORGENESIS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), EVOGENE LTD (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), IMMUTEP LTD (ASX), AZIYO BIOLOGICS INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), CONTRAFECT CORP (NASDAQ), ENZO BIOCHEM INC (NYSE), LEAP THERAPEUTICS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), LONGEVERON INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), ARAVIVE INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), ONCOLYTICS BIOTECH INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), SYNLOGIC INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), INFLARX N V (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), RECRO PHARMA INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), SAVARA INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), UNI-BIO GROUP (HKEx), COHBAR INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), LEAF RESOURCES LTD (ASX), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), ADVAXIS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), CHIMERIC THERAPEUTICS LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), MONOPAR THERAPEUTICS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), VACCINEX INC (NASDAQ), REGENT PACIFIC (HKEx), VIRIDIAN THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), GENETIC TECHNOLOGIES (ASX), WINDTREE THERAPEUTICS INC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), BIOCARDIA INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), MEMPHASYS LTD (ASX), OPIANT PHARMACEUTICALS INC (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), SOLIGENIX INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), CYCLACEL PHARMACEUTICALS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), PRECIPIO INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), BIOTRON (ASX), CYCLO THERAPEUTICS INC (NASDAQ), AUSTRALIAN PRIMARY HEMP LTD (ASX), PHIO PHARMACEUTICALS CORP (NASDAQ), PATRYS LIMITED (ASX), Suntar Eco-City (SGX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), ADALTA LTD (ASX), HISTOGEN INC (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), PLUS THERAPEUTICS INC (NASDAQ), GEOVAX LABS INC (NASDAQ), REGENEUS LTD (ASX), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), RHINOMED LIMITED (ASX), SENECA BIOPHARMA INC (NASDAQ), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), SENESTECH INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), NANOLLOSE LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), HAO WEN HLDGS (HKEx), CRYOSITE (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.160
-12.50 %
10 Days --0.170
-13.18 %
20 Days --0.370
-24.83 %
Medium Term Return 3 Months --0.010
-0.88 %
6 Months -+0.401
+55.77 %
1 Year -+0.214
+23.62 %
Long Term Return 2 Years --0.050
-4.27 %
3 Years -+0.100
+9.80 %
Annualised Return Annualised --
+3.17 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.490 - 2.220 Change From 1 Year Low +0.630 % Change From 1 Year Low (%) +128.57
Change From 1 Year High -1.100 % Change From 1 Year High (%) -49.55
2 Years Range 0.490 - 2.490 Change From 2 Years Low +0.630 % Change From 2 Years Low (%) +128.57
Change From 2 Years High -1.370 % Change From 2 Years High (%) -55.02
5 Years Range 0.324 - 3.950 Change From 5 Years Low +0.796 % Change From 5 Years Low (%) +246.00
Change From 5 Years High -2.830 % Change From 5 Years High (%) -71.65
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company, which focuses on enabling the delivery of life-changing medicines using its LNC platform technology. The company's proprietary, disruptive technology utilizes lipid nano-crystals which can encapsulate small molecule drugs, oligonucleotides, vaccines, peptides, proteins, and other medicines potentially making them safer, more tolerable, less toxic, and orally bioavailable. Its anti-fungal product candidate, MAT2203, delivers broad-spectrum fungicidal agent, amphotericin B, and is being developed to prevent invasive fungal infections in patients with acute lymphoblastic leukemia. The company was founded by Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.

Historical Price Data

Date Open High Low Close Volume VWAP
08 Mar 2021 1.120 1.200 1.080 1.120 1,834,290 -
05 Mar 2021 1.110 1.170 1.000 1.120 3,064,640 -
04 Mar 2021 1.180 1.190 1.030 1.070 4,461,208 -
03 Mar 2021 1.280 1.280 1.160 1.180 2,176,780 -
02 Mar 2021 1.300 1.320 1.250 1.280 1,624,791 -
01 Mar 2021 1.260 1.345 1.250 1.300 2,194,150 -
26 Feb 2021 1.260 1.340 1.210 1.210 2,665,319 -
25 Feb 2021 1.350 1.380 1.250 1.290 3,126,808 -
24 Feb 2021 1.290 1.430 1.250 1.370 2,860,689 -
23 Feb 2021 1.270 1.290 1.150 1.290 4,895,538 -
22 Feb 2021 1.380 1.430 1.330 1.350 3,271,293 -
19 Feb 2021 1.400 1.410 1.360 1.410 2,119,545 -
18 Feb 2021 1.390 1.440 1.330 1.410 3,627,398 -
17 Feb 2021 1.550 1.550 1.390 1.400 4,649,554 -
16 Feb 2021 1.490 1.580 1.380 1.530 9,410,433 -
12 Feb 2021 1.370 1.470 1.320 1.420 3,592,139 -
11 Feb 2021 1.430 1.440 1.350 1.420 5,398,211 -
10 Feb 2021 1.580 1.580 1.310 1.430 7,612,494 -
09 Feb 2021 1.490 1.550 1.440 1.490 9,346,173 -
08 Feb 2021 1.190 1.450 1.190 1.430 11,587,310 -
05 Feb 2021 1.230 1.238 1.170 1.210 6,421,695 -
04 Feb 2021 1.300 1.310 1.170 1.230 9,167,857 -
Summary
Current 2 Weeks
(23 Feb 2021 to 08 Mar 2021)
1.270 1.430 1.000 1.120 28,904,213 -
Previous 2 Weeks
(08 Feb 2021 to 22 Feb 2021)
1.190 1.450 1.000 1.350 60,614,550 -
4 Weeks from
(08 Jan 2021 to 05 Feb 2021)
1.520 1.560 1.000 1.210 132,078,758 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.